MARTHA REYES: Open Payments
NPI 1477043594 · GRANTS, NM. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,240 in 43 payments from 15 companies in 2025. Trend: 2023 $118 · 2024 $113 · 2025 $1,240
Food & beverage: $1,240
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 10 | $218 |
| Novo Nordisk Inc | 6 | $205 |
| Phathom Pharmaceuticals, Inc. | 2 | $205 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 6 | $176 |
| Exact Sciences Corporation | 4 | $94 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $91 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $40 |
| Inspire Medical Systems, Inc. | 1 | $35 |
| Merck Sharp & Dohme LLC | 2 | $35 |
| PFIZER INC. | 2 | $32 |
Products named: VOQUEZNA, XIFAXAN, Ozempic, ZEPBOUND, MOUNJARO, Kerendia, Cologuard Collection Kit, JARDIANCE.
Industry payments across NM — which companies pay providers there.
